Literature DB >> 19011693

Aerosol Deposition in the Extrathoracic Region.

Yung Sung Cheng1.   

Abstract

The extrathoracic region, including the nasal and oral passages, pharynx, and larynx, is the entrance to the human respiratory tract and the first line of defense against inhaled air pollutants. Estimates of regional deposition in the thoracic region are based on data obtained with human volunteers, and that data showed great variability in the magnitude of deposition under similar experimental conditions. In the past decade, studies with physical casts and computational fluid dynamic simulation have improved upon the understanding of deposition mechanisms and have shown some association of aerosol deposition with airway geometry. This information has been analyzed to improve deposition equations, which incorporate characteristic airway dimensions to address intersubject variability of deposition during nasal breathing. Deposition in the nasal and oral airways is dominated by the inertial mechanism for particles >0.5 mum and by the diffusion mechanism for particles <0.5 mum. Deposition data from adult and child nasal airway casts with detailed geometric data can be expressed as E(n) = 1 - exp(-110 Stk), where the Stokes number is a function of the aerodynamic diameter (d(a)), flow rate (Q), and the characteristic nasal airway dimension, the minimum cross-sectional area (A(min)). In vivo data for each human volunteer follow the equation when the appropriate value of A(min) is used. For the diffusion deposition, in vivo deposition data for ultrafine particles and in vivo and cast data for radon progeny were used to derive the following deposition: En=1-exp(-0.355Sf4.14D0.5Q-0.28), where S(f) is the normalized surface area in the turbinate region of the nasal airway, and D is the diffusion coefficient. The constant is not significantly different for inspiratory deposition than for expiratory deposition. By using the appropriate characteristic dimension, S(f), one can predict the variability of in vivo nasal deposition fairly well. Similar equations for impaction and diffusion deposition were obtained for deposition during oral breathing. However, the equations did not include airway dimensions for intersubject variability, because the data set did not have airway dimension measurements. Further studies with characteristic airway dimensions for oral deposition are needed. These equations could be used in lung deposition models to improve estimates of extrathoracic deposition and intersubject variability.

Entities:  

Year:  2003        PMID: 19011693      PMCID: PMC2582879          DOI: 10.1080/02786820300906

Source DB:  PubMed          Journal:  Aerosol Sci Technol        ISSN: 0278-6826            Impact factor:   2.908


  12 in total

1.  Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway.

Authors:  Y S Cheng; T D Holmes; J Gao; R A Guilmette; S Li; Y Surakitbanharn; C Rowlings
Journal:  J Aerosol Med       Date:  2001

2.  Mouth and oropharyngeal deposition of pharmaceutical aerosols.

Authors:  A R Clark; S P Newman; N Dasovich
Journal:  J Aerosol Med       Date:  1998

3.  Penetration of air-borne particulates through the human nose.

Authors:  H D LANDAHL; S BLACK
Journal:  J Ind Hyg Toxicol       Date:  1947-07

4.  Measurements of airway dimensions and calculation of mass transfer characteristics of the human oral passage.

Authors:  K H Cheng; Y S Cheng; H C Yeh; D L Swift
Journal:  J Biomech Eng       Date:  1997-11       Impact factor: 2.097

5.  Deposition of large particles in human lung.

Authors:  M Svartengren; R Falk; L Linnman; K Philipson; P Camner
Journal:  Exp Lung Res       Date:  1987       Impact factor: 2.459

6.  The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract.

Authors:  R F Hounam; A Black; M Walsh
Journal:  Inhaled Part       Date:  1970

7.  The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract.

Authors:  M Lippmann; R E Albert
Journal:  Am Ind Hyg Assoc J       Date:  1969 May-Jun

8.  Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.

Authors:  Y S Cheng; C S Fu; D Yazzie; Y Zhou
Journal:  J Aerosol Med       Date:  2001

9.  Statistical analysis of aerosol deposition in nose and mouth.

Authors:  C P Yu; C K Diu; T T Soong
Journal:  Am Ind Hyg Assoc J       Date:  1981-10

10.  Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.

Authors:  W Stahlhofen; J Gebhart; J Heyder
Journal:  Am Ind Hyg Assoc J       Date:  1980-06
View more
  33 in total

1.  Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.

Authors:  Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2010-05-08       Impact factor: 4.200

2.  Effect of intersubject variability of extrathoracic morphometry, lung airways dimensions and respiratory parameters on particle deposition.

Authors:  Majid Hussain; Winker-Heil Renate; Hofmann Werner
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

3.  Importance of airway geometry and respiratory parameters variability for particle deposition in the human respiratory tract.

Authors:  Tomasz R Sosnowski
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

4.  Characterization of Nanoaerosol Size Change During Enhanced Condensational Growth.

Authors:  P Worth Longest; James T McLeskey; Michael Hindle
Journal:  Aerosol Sci Technol       Date:  2010-06-01       Impact factor: 2.908

5.  Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).

Authors:  P Worth Longest; Geng Tian; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-16       Impact factor: 2.849

6.  Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.

Authors:  Ross L Walenga; P Worth Longest; Anubhav Kaviratna; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-01-11       Impact factor: 2.849

7.  Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

Authors:  Dale Farkas; Michael Hindle; Serena Bonasera; Karl Bass; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-08-29       Impact factor: 2.849

8.  Exposure assessment and associated lung deposition calculations for vehicular exhaust in four metropolitan cities of Pakistan.

Authors:  Hussain Majid; Khan Alam; Pierre Madl; Werner Hofmann
Journal:  Environ Monit Assess       Date:  2012-10-31       Impact factor: 2.513

9.  Targeted Lung Delivery of Nasally Administered Aerosols.

Authors:  Geng Tian; Michael Hindle; P Worth Longest
Journal:  Aerosol Sci Technol       Date:  2014       Impact factor: 2.908

10.  Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery.

Authors:  Po-Chang Chiang; Jason W Alsup; Yurong Lai; Yiding Hu; Bruce R Heyde; David Tung
Journal:  Nanoscale Res Lett       Date:  2009-01-06       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.